MedPath
NMPA Approval

Lercanidipine Hydrochloride Tablets

国药准字HJ20160257

recordati s.p.a.

April 25, 2022

H20160257

Drug Information

盐酸乐卡地平片

再宁平

再宁平

片剂

20mg

化学药品

April 25, 2022

April 24, 2027

Company Information

Applicant Company

recordati s.p.a.

Via M. Civitali, 1-20148 Milano, Italy

Manufacturing Company

recordati s.p.a.

Via M. Civitali, 1-20148 Milano, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸乐卡地平片 - NMPA 批准文号 | MedPath